Aarti Drugs declares Q1 FY27 Audited Standalone & Consolidated Results

Aarti Drugs Ltd's Board of Directors, at its meeting on July 31, 2026, considered and approved the Audited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026 (Q1 FY27). The company informed that the Statutory Auditors have carried out the audit and expressed an unmodified audit opinion on these financial results. The results will be published in newspapers as per SEBI regulations and made available on the company's website and stock exchange platforms. The board meeting commenced at 2:30 PM and concluded at 5:20 PM. An exceptional item related to the write-off of Capital Work-in-Progress was noted in the results.